»Ê¼Ò»ªÈË

FTSE 350 Review: UK pharma companies, not known for their weight-loss products, are prospering elsewhere

FTSE 350 Review: The capital-intensive businesses have consolidated and are now growing their cash flows

FTSE 350 Review: The sector is diverse, yet AI disruption fears are gripping almost every stock

FTSE 350 Review: Rising defence spending and strained public services are driving record bid pipelines for contractors

FTSE 350 Review: The emergence of new bespoke tools is changing the way companies procure software

FTSE 350 Review: The sector’s premium rating continues to quietly wither away

FTSE 350 Review: Not all companies need the cycle to turn, but the gap between quality and the rest is widening

Dan Jones explores the key themes, issues and opportunities for the sectors making up the London market